纵横研报
Ticker Detail

688617.SHG

¥213+4.41% 惠泰医疗 Medical Devices
00Reports China 医疗健康
APT Medical Inc
医疗健康 · 医疗器械

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addition, it provides OEM and ODM services comprising project design and development, customization, and volume OEM; and customized products consisting of catheters, guidewires, and delivery systems, as well as nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.

MARKET 市值 29.33B CNY PE 33.8x 52W ¥176.28 – ¥335.81 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY 24.8% ROE 29.7% 营业利润率 37.5% 净利润率 31.8%
ANALYST 股息率 0.49%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制